Canadians’ opinions towards COVID-19 data-sharing: a national cross-sectional survey

Author:

Savic Kallesoe Sarah AORCID,Rabbani TianORCID,Gill Erin E,Brinkman Fiona,Griffiths Emma J,Zawati Ma'n,Liu Hanshi,Palmour Nicole,Joly YannORCID,Hsiao William W L

Abstract

ObjectivesCOVID-19 research has significantly contributed to pandemic response and the enhancement of public health capacity. COVID-19 data collected by provincial/territorial health authorities in Canada are valuable for research advancement yet not readily available to the public, including researchers. To inform developments in public health data-sharing in Canada, we explored Canadians’ opinions of public health authorities sharing deidentified individual-level COVID-19 data publicly.Design/setting/interventions/outcomesA national cross-sectional survey was administered in Canada in March 2022, assessing Canadians’ opinions on publicly sharing COVID-19 datatypes. Market research firm Léger was employed for recruitment and data collection.ParticipantsAnyone greater than or equal to 18 years and currently living in Canada.Results4981 participants completed the survey with a 92.3% response rate. 79.7% were supportive of provincial/territorial authorities publicly sharing deidentified COVID-19 data, while 20.3% were hesitant/averse/unsure. Datatypes most supported for being shared publicly were symptoms (83.0% in support), geographical region (82.6%) and COVID-19 vaccination status (81.7%). Datatypes with the most aversion were employment sector (27.4% averse), postal area (26.7%) and international travel history (19.7%). Generally supportive Canadians were characterised as being ≥50 years, with higher education, and being vaccinated against COVID-19 at least once. Vaccination status was the most influential predictor of data-sharing opinion, with respondents who were ever vaccinated being 4.20 times more likely (95% CI 3.21 to 5.48, p=0.000) to be generally supportive of data-sharing than those unvaccinated.ConclusionsThese findings suggest that the Canadian public is generally favourable to deidentified data-sharing. Identifying factors that are likely to improve attitudes towards data-sharing are useful to stakeholders involved in data-sharing initiatives, such as public health agencies, in informing the development of public health communication and data-sharing policies. As Canada progresses through the COVID-19 pandemic, and with limited testing and reporting of COVID-19 data, it is essential to improve deidentified data-sharing given the public’s general support for these efforts.

Funder

Genome Canada

Publisher

BMJ

Subject

General Medicine

Reference37 articles.

1. Government of Canada . Canada’s health care system [Internet], 2016. Available: https://www.canada.ca/en/health-canada/services/canada-health-care-system.html [Accessed 19 Apr 2022].

2. National Human Genome Research Institute . Genomics and Medicine [Internet], 2020. Available: https://www.genome.gov/health/Genomics-and-Medicine [Accessed 05 Aug 2021].

3. A review of cross organizational healthcare data sharing;Azarm-Daigle;Procedia Comput Sci,2015

4. Government of Canada . Public Health Agency of Canada. Expert Advisory Group Report 3: Toward a world-class health data system [Internet], 2022. Available: https://www.canada.ca/en/public-health/corporate/mandate/about-agency/external-advisory-bodies/list/pan-canadian-health-data-strategy-reports-summaries/expert-advisory-group-report-03-toward-world-class-health-data-system.html [Accessed 02 Jun 2022].

5. Institute of Medicine (US) . Chapter 5: standardization to enhance data sharing. In: Sharing Clinical Research Data: Workshop Summary [Internet]. Sharing Clinical Research Data: Workshop Summary. US: National Academies Press, 2013: 43–55. https://www.ncbi.nlm.nih.gov/books/NBK137818/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3